Results 71 to 80 of about 42,305 (336)

Efficacy and Safety of Intratympanic Botulinum Toxin Injection on Middle Ear Myoclonic Tinnitus

open access: yesThe Laryngoscope, EarlyView.
Intratympanic Botulinum toxin (IT‐BTX) injection appears to be an effective and safe treatment for MEMT, significantly reducing tinnitus‐related symptoms without complications. In a retrospective study of 57 patients, THI scores and VAS measures for loudness, awareness, annoyance, and life impact improved significantly over 6 months.
Ji Hyung Lim   +8 more
wiley   +1 more source

Bacterial Toxins: Friends or Foes?

open access: yesEmerging Infectious Diseases, 1999
Many emerging and reemerging bacterial pathogens synthesize toxins that serve as primary virulence factors. We highlight seven bacterial toxins produced by well-established or newly emergent pathogenic microbes.
Clare K. Schmitt   +2 more
doaj   +1 more source

Botulinum toxin therapy: functional silencing of salivary disorders. [PDF]

open access: yes, 2017
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary ...
Lovato, A   +4 more
core  

Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial [PDF]

open access: yes, 2012
Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources.
Christopher Price   +16 more
core   +3 more sources

Botulinum Toxin-A in Dystonia

open access: yesPediatric Neurology Briefs, 1990
A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology concludes that local injection of type A botulinum toxin (Botox) is proven as a safe and efficacious modality for the treatment of blepharospasm, cervical dystonia, and hemifacial spasm.
openaire   +3 more sources

Validation of an Endoscopic Landmark for Injection of Internal Branch of Superior Laryngeal Nerve

open access: yesThe Laryngoscope, EarlyView.
This study validates a transnasal endoscopic approach to target the internal branch of the superior laryngeal nerve (iSLN) via the piriform sinus. Cadaveric analysis showed this method enables precise localization with minimal variability, offering a promising technique for treating laryngeal sensory dysfunction.
Yuki Tanigami   +4 more
wiley   +1 more source

Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris. [PDF]

open access: yes, 2005
RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'.
Ellar, David J, Gurkan, Cemal
core   +2 more sources

Botulinum toxin type A in chronic neuropathic pain in refractory leprosy

open access: yesArquivos de Neuro-Psiquiatria
Neuropathic pain is a chronic syndrome that is difficult to treat and often affects patients with leprosy. Recommended treatment includes the the use of analgesic drugs, codeine, tricyclic antidepressants, neuroleptics, anticonvulsants and thalidomide ...
Emanuel de Jesus Soares de Sousa   +4 more
doaj   +1 more source

Intratumoral Nerve Phased Development: A Promising Therapeutic Target

open access: yesMedicine Bulletin, EarlyView.
ABSTRACT The nervous system has emerged as a critical regulator of tumor biology, engaging in dynamic crosstalk with cancer cells. Although the protumorigenic role of innervation is well established, increasing attention is now directed toward reciprocal influences—how tumors actively shape and remodel local nerve networks within the tumor ...
Xiangxian Che   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy